Navigating a Decentralized Trial Model and the Changing Clinical Landscape During COVID-19

Rho’s Sharon Duffy gives a top-down analysis of the decentralized trial model’s benefits and impact on the industry in the February issue of Applied Clinical Trials. Read the issue here.